Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Infectious diseases

Managing Malaria with Smarter Sampling

| Jonathan James

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

Disease Area Neuroscience

Holding Back the Years

| Maryam Mahdi

Seeking inspiration from plants in the fight against Alzheimer’s disease.

Disease Area Infectious diseases

The Intersection of Infection and Biodefense

| Marcus Horwitz

Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.

Disease Area Infectious diseases

Fighting the Flu

| Jonathan James

A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza.

Disease Area Cancer

The Relentless Cancer Researcher

| Jonathan James

Sitting Down With… Ingun Holen, Professor of Bone Oncology at the University of Sheffield Medical School, Sheffield, UK.

Disease Area Pain & critical care

Putting Your Back into It

| Jonathan James

Progress in tissue engineering may offer hope to patients suffering from debilitating intervertebral disc degeneration.

Disease Area Neurological

A Neural Precedent

| Jonathan James

Interneuron activity suggests that there’s more to the story of seizure onset

Disease Area Neuroscience

Brain Network Manipulation

| Jonathan James

Cutting-edge imaging, predictive modeling and gene therapy combine for a new direction in neurodegenerative disease research

Disease Area Infectious diseases

Andes Antibody Advancement

| Jonathan James

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

Disease Area Cancer

More than METs the Eye

| Jonathan James

The role of different types of MET mutation in lung cancer could demand a rethink of treatments.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register